STOCK TITAN

[Form 4] Penumbra Inc Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4

Penumbra Inc. (PEN) director Thomas C. Wilder reported a sale of 186 shares of common stock on 10/01/2025 at a price of $253.93 per share. The filing states the sale was executed under the reporting person’s Rule 10b5-1 trading plan. After the sale the report shows the reporting person beneficially owns 186 shares directly and 4,506 shares indirectly through the Thomas and Catharine Wilder Family Trust dated March 31, 2006. The filing also notes that a portion of the reported shares are subject to vesting.

The Form 4 was signed by an attorney-in-fact on behalf of Mr. Wilder on 10/03/2025. No options, derivative transactions, earnings figures, or other corporate actions are disclosed in this form; it records a single small open-market sale and the current direct and indirect holdings disclosed by the reporting person.

Penumbra Inc. (PEN) il direttore Thomas C. Wilder ha riportato la vendita di 186 azioni comuni il 01/10/2025 a un prezzo di $253,93 per azione. La comunicazione indica che la vendita è stata eseguita ai sensi del piano di trading Rule 10b5-1 del soggetto reportante. Dopo la vendita la relazione mostra che il soggetto reportante possiede direttamente 186 azioni e indirettamente 4.506 azioni tramite il Thomas and Catharine Wilder Family Trust datato 31 marzo 2006. La comunicazione segnala anche che una porzione delle azioni riportate è soggetta a vesting.

Il Form 4 è stato firmato da un procuratore in nome del signor Wilder il 03/10/2025. Nessuna opzione, transazione derivata, cifra di utili o altre azioni societarie sono disclosure in questo modulo; registra una singola piccola vendita sul mercato aperto e le attuali detenzioni dirette e indirecte come riportato dalla persona reportante.

Penumbra Inc. (PEN) el director Thomas C. Wilder informó de la venta de 186 acciones ordinarias el 01/10/2025 a un precio de $253,93 por acción. El registro indica que la venta se ejecutó conforme al plan de negociación Rule 10b5-1 del informante. Después de la venta, el informe muestra que la persona reportante posee de forma directa 186 acciones y de forma indirecta 4.506 acciones a través del Thomas and Catharine Wilder Family Trust con fecha del 31 de marzo de 2006. El registro también señala que una parte de las acciones declaradas está sujeta a vesting.

El Formulario 4 fue firmado por un apoderado en nombre del señor Wilder el 03/10/2025. No se divulgan opciones, transacciones derivadas, cifras de ingresos u otras acciones corporativas en este formulario; registra una sola pequeña venta en el mercado abierto y las participaciones directas e indirectas actuales que figura el informante.

Penumbra Inc. (PEN) 이사 Thomas C. Wilder가 186 주의 보통주를 2025년 10월 1일에 주가 $253.93로 매도했다고 보고했습니다. 제출서는 매도가 보고자 의 규칙 10b5-1 거래 계획에 따라 실행되었음을 명시합니다. 매도 후 보고서는 보고자가 직접 보유한 186주와 간접적으로 4,506주를 2006년 3월 31일자의 Thomas and Catharine Wilder Family Trust를 통해 보유하고 있음을 보여줍니다. 제출서는 또한 보고된 주식의 일부가 가속 vesting 대상임을 주 note합니다.

4형은 2025년 10월 3일에 Wilder 씨를 대신하여 대리인이 서명했습니다. 이 양식에는 옵션, 파생 거래, 수익 수치 또는 기타 기업 행동은 기재되어 있지 않으며, 한 건의 소량의 공개 시장 매도와 보고자에 의해 공개된 현재의 직접 및 간접 보유를 기록합니다.

Penumbra Inc. (PEN) le administrateur Thomas C. Wilder a annoncé la vente de 186 actions ordinaires le 01/10/2025 à un prix de $253,93 par action. Le dépôt indique que la vente a été exécutée dans le cadre du plan de négociation Rule 10b5-1 du déclarant. Après la vente, le rapport indique que la personne déclarante détient directement 186 actions et indirectement 4 506 actions par le biais du Thomas and Catharine Wilder Family Trust daté du 31 mars 2006. Le dépôt note également qu'une partie des actions déclarées est soumise à vesting.

Le Formulaire 4 a été signé par un mandataire au nom de M. Wilder le 03/10/2025. Aucune option, transaction dérivée, chiffre de gain ou autre action d'entreprise n'est divulgué dans ce formulaire ; il enregistre une seule petite vente sur le marché libre et les positions directes et indirectes actuelles telles que déclarées par la personne.

Penumbra Inc. (PEN) Direktor Thomas C. Wilder meldete den Verkauf von 186 Stammaktien am 01.10.2025 zu einem Preis von $253,93 pro Aktie. Die Einreichung gibt an, dass der Verkauf im Rahmen des Handelsplans Rule 10b5-1 der meldenden Person durchgeführt wurde. Nach dem Verkauf zeigt der Bericht, dass die meldende Person direkt 186 Aktien und indirekt über den Thomas and Catharine Wilder Family Trust vom 31. März 2006 4.506 Aktien besitzt. Die Einreichung stellt außerdem fest, dass ein Teil der gemeldeten Aktien vesting unterliegt.

Das Formular 4 wurde von einem Bevollmächtigten im Namen von Mr. Wilder am 03.10.2025 unterzeichnet. In diesem Formular werden keine Optionen, Derivate, Ertragszahlen oder andere Unternehmensevents offengelegt; es verzeichnet einen einzelnen kleinen Off-Market-Verkauf und die aktuellen direkten und indirekten Beteiligungen, wie sie von der meldenden Person angegeben sind.

Penumbra Inc. (PEN) أبلغ المدير توماس ك. وايلدر عن بيع 186 سهماً من الأسهم العادية في 01/10/2025 بسعر $253.93 للسهم الواحد. يذكر الملف أن البيع تم تنفيذه وفق خطة التداول Rule 10b5-1 الخاصة بالشخص المبلغ. بعد البيع، يُظهر التقرير أن الشخص المفصح يمتلك بشكل مباشر 186 سهماً وبشكل غير مباشر من خلال Thomas and Catharine Wilder Family Trust dated March 31, 2006 ما مجموعه 4,506 سهماً. كما تشير الوثيقة إلى أن جزءاً من الأسهم المصرّح عنها خاضع لـ vesting.

تم توقيع نموذج 4 من قبل وكيل قانوني نيابة عن السيد وايلدر في 03/10/2025. لا يتم الإفصاح عن أي خيارات، معاملات مشتقة، أرقام أرباح، أو إجراءات شركات أخرى في هذا النموذج؛ فهو يسجل بيعاً واحداً بسيطاً في السوق المفتوحة ويمثل الحيازات المباشرة وغير المباشرة الحالية كما يذكرها الشخص المبلغ.

Penumbra Inc. (PEN) 董事 Thomas C. Wilder 于 2025/10/01 以每股 $253.93 的价格出售了 186 股普通股。文件表明此笔出售是根据披露人Rule 10b5-1 交易计划执行的。出售后,报告显示披露人直接持有 186 股,间接通过 Thomas and Catharine Wilder Family Trust,成立于 2006 年 3 月 31 日 间接持有 4,506 股。文件还指出,所报股份中的一部分受限于 vesting。

Form 4 由代理律师代表 Wilder 先生在 2025/10/03 签署。本表格未披露任何期权、衍生交易、收益数字或其他公司行动;它记录了一笔在公开市场上的小额卖出,以及披露人当前的直接和间接持有。

Positive
  • Sale executed under a Rule 10b5-1 trading plan, indicating preplanned transaction and affirmative defense to insider trading concerns
Negative
  • None.

Insights

Small preplanned director sale under a Rule 10b5-1 plan; holdings remain primarily held in trust.

What it means: The director sold 186 shares on 10/01/2025 at $253.93 under a documented 10b5-1 trading plan, which indicates the transaction was preauthorized and designed to provide an affirmative defense to insider trading claims.

Why it matters: Because the sale was conducted under a 10b5-1 plan and the reporting person still retains 186 direct shares plus 4,506 indirect shares in a family trust, this filing signals routine monetization rather than an unplanned disposition tied to undisclosed company developments. The filing also discloses that some reported shares are subject to vesting, which affects the immediate liquidity of the reporting person's position.

Penumbra Inc. (PEN) il direttore Thomas C. Wilder ha riportato la vendita di 186 azioni comuni il 01/10/2025 a un prezzo di $253,93 per azione. La comunicazione indica che la vendita è stata eseguita ai sensi del piano di trading Rule 10b5-1 del soggetto reportante. Dopo la vendita la relazione mostra che il soggetto reportante possiede direttamente 186 azioni e indirettamente 4.506 azioni tramite il Thomas and Catharine Wilder Family Trust datato 31 marzo 2006. La comunicazione segnala anche che una porzione delle azioni riportate è soggetta a vesting.

Il Form 4 è stato firmato da un procuratore in nome del signor Wilder il 03/10/2025. Nessuna opzione, transazione derivata, cifra di utili o altre azioni societarie sono disclosure in questo modulo; registra una singola piccola vendita sul mercato aperto e le attuali detenzioni dirette e indirecte come riportato dalla persona reportante.

Penumbra Inc. (PEN) el director Thomas C. Wilder informó de la venta de 186 acciones ordinarias el 01/10/2025 a un precio de $253,93 por acción. El registro indica que la venta se ejecutó conforme al plan de negociación Rule 10b5-1 del informante. Después de la venta, el informe muestra que la persona reportante posee de forma directa 186 acciones y de forma indirecta 4.506 acciones a través del Thomas and Catharine Wilder Family Trust con fecha del 31 de marzo de 2006. El registro también señala que una parte de las acciones declaradas está sujeta a vesting.

El Formulario 4 fue firmado por un apoderado en nombre del señor Wilder el 03/10/2025. No se divulgan opciones, transacciones derivadas, cifras de ingresos u otras acciones corporativas en este formulario; registra una sola pequeña venta en el mercado abierto y las participaciones directas e indirectas actuales que figura el informante.

Penumbra Inc. (PEN) 이사 Thomas C. Wilder가 186 주의 보통주를 2025년 10월 1일에 주가 $253.93로 매도했다고 보고했습니다. 제출서는 매도가 보고자 의 규칙 10b5-1 거래 계획에 따라 실행되었음을 명시합니다. 매도 후 보고서는 보고자가 직접 보유한 186주와 간접적으로 4,506주를 2006년 3월 31일자의 Thomas and Catharine Wilder Family Trust를 통해 보유하고 있음을 보여줍니다. 제출서는 또한 보고된 주식의 일부가 가속 vesting 대상임을 주 note합니다.

4형은 2025년 10월 3일에 Wilder 씨를 대신하여 대리인이 서명했습니다. 이 양식에는 옵션, 파생 거래, 수익 수치 또는 기타 기업 행동은 기재되어 있지 않으며, 한 건의 소량의 공개 시장 매도와 보고자에 의해 공개된 현재의 직접 및 간접 보유를 기록합니다.

Penumbra Inc. (PEN) le administrateur Thomas C. Wilder a annoncé la vente de 186 actions ordinaires le 01/10/2025 à un prix de $253,93 par action. Le dépôt indique que la vente a été exécutée dans le cadre du plan de négociation Rule 10b5-1 du déclarant. Après la vente, le rapport indique que la personne déclarante détient directement 186 actions et indirectement 4 506 actions par le biais du Thomas and Catharine Wilder Family Trust daté du 31 mars 2006. Le dépôt note également qu'une partie des actions déclarées est soumise à vesting.

Le Formulaire 4 a été signé par un mandataire au nom de M. Wilder le 03/10/2025. Aucune option, transaction dérivée, chiffre de gain ou autre action d'entreprise n'est divulgué dans ce formulaire ; il enregistre une seule petite vente sur le marché libre et les positions directes et indirectes actuelles telles que déclarées par la personne.

Penumbra Inc. (PEN) Direktor Thomas C. Wilder meldete den Verkauf von 186 Stammaktien am 01.10.2025 zu einem Preis von $253,93 pro Aktie. Die Einreichung gibt an, dass der Verkauf im Rahmen des Handelsplans Rule 10b5-1 der meldenden Person durchgeführt wurde. Nach dem Verkauf zeigt der Bericht, dass die meldende Person direkt 186 Aktien und indirekt über den Thomas and Catharine Wilder Family Trust vom 31. März 2006 4.506 Aktien besitzt. Die Einreichung stellt außerdem fest, dass ein Teil der gemeldeten Aktien vesting unterliegt.

Das Formular 4 wurde von einem Bevollmächtigten im Namen von Mr. Wilder am 03.10.2025 unterzeichnet. In diesem Formular werden keine Optionen, Derivate, Ertragszahlen oder andere Unternehmensevents offengelegt; es verzeichnet einen einzelnen kleinen Off-Market-Verkauf und die aktuellen direkten und indirekten Beteiligungen, wie sie von der meldenden Person angegeben sind.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Wilder Thomas

(Last) (First) (Middle)
ONE PENUMBRA PLACE

(Street)
ALAMEDA CA 94502

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Penumbra Inc [ PEN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/01/2025 S(1) 186 D $253.93 186(2) D
Common Stock 4,506 I By Trust(3)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
2. A portion of these shares is subject to vesting.
3. Shares are held by the Thomas and Catharine Wilder Family Trust dated March 31, 2006.
Remarks:
/s/ Johanna Roberts, as attorney-in-fact for Thomas C. Wilder 10/03/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Penumbra director Thomas C. Wilder sell in the Form 4 (PEN)?

The Form 4 reports a sale of 186 shares of Penumbra common stock on 10/01/2025 at $253.93 per share.

Was the sale by the Penumbra director part of a 10b5-1 trading plan?

Yes. The filing states the sales were effected pursuant to the reporting person’s Rule 10b5-1 trading plan.

How many Penumbra shares does Thomas C. Wilder beneficially own after the reported transaction?

The filing shows Mr. Wilder beneficially owns 186 shares directly and 4,506 shares indirectly via the family trust.

Are any of the reported shares subject to vesting?

Yes. The Form 4 states that a portion of the reported shares is subject to vesting.

Who holds the indirect shares disclosed by the reporting person?

The indirect holdings of 4,506 shares are held by the Thomas and Catharine Wilder Family Trust dated March 31, 2006.
Penumbra Inc

NYSE:PEN

PEN Rankings

PEN Latest News

PEN Latest SEC Filings

PEN Stock Data

9.99B
37.51M
3.66%
93.38%
4.59%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
ALAMEDA